Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients

NCT00327288 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer
Breast Cancer
Prostate Cancer

Interventions

DRUG: imexon
DRUG: docetaxel

Sponsor

AmpliMed Corporation